Argos Therapeutics (ARGS) Tops Q3 EPS by 3c

November 14, 2016 6:58 AM EST
Get Alerts ARGS Hot Sheet
Trade ARGS Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Argos Therapeutics (NASDAQ: ARGS) reported Q3 EPS of ($0.32), $0.03 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $145.76 thousand versus the consensus estimate of $250 thousand.

For earnings history and earnings-related data on Argos Therapeutics (ARGS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment